Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$14.74
$14.62
$6.38
$14.76
$1.87B0.193.08 million shs3.45 million shs
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$7.16
+2.1%
$8.08
$6.07
$21.02
$552.76M1.381.12 million shs1.17 million shs
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$31.33
$31.22
$19.45
$31.79
$2.77B0.731.24 million shsN/A
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
$1.83
+3.4%
$1.82
$1.15
$42.20
$88.40M-2.312.97 million shs1.05 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00%0.00%0.00%0.00%0.00%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
0.00%-5.84%+1.74%-17.07%-62.32%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
0.00%0.00%+1.36%+1.03%+23.83%
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
0.00%+9.94%+39.37%-23.71%-91.25%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/AN/AN/AN/A
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
4.7924 of 5 stars
3.02.00.03.92.63.33.8
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
2.0024 of 5 stars
1.03.02.51.70.01.72.5
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
3.6652 of 5 stars
3.32.00.04.71.60.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00
N/AN/AN/A
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.00
Hold$12.5074.70% Upside
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
2.09
Hold$26.57-15.19% Downside
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
2.50
Moderate Buy$54.502,878.14% Upside

Current Analyst Ratings Breakdown

Latest OMI, PDCO, BLU, and SAVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $11.00
3/25/2025
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$2.00 ➝ $2.00
3/10/2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$14.00 ➝ $10.00
3/4/2025
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/3/2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$10.00 ➝ $11.00
2/25/2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$14.00 ➝ $10.00
2/13/2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$25.00 ➝ $13.00
(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$15K124,613.93N/AN/A$3.09 per share4.77
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$10.70B0.05$5.72 per share1.25$12.08 per share0.59
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$6.51B0.43$3.42 per share9.17$11.18 per share2.80
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
N/AN/AN/AN/A$3.26 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BELLUS Health Inc. stock logo
BLU
BELLUS Health
-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/A
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
-$41.30M-$4.75N/A4.070.20-0.46%14.60%2.51%7/31/2025 (Estimated)
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$185.93M$1.5418.3212.842.712.37%19.77%6.66%6/17/2025 (Estimated)
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
-$97.22M-$1.45N/AN/AN/AN/A-88.05%-64.98%N/A

Latest OMI, PDCO, BLU, and SAVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/10/2025Q1 2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.20$0.23+$0.03N/AN/AN/A
5/8/2025Q1 2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.20$0.23+$0.03-$0.32$2.66 billion$2.63 billion
5/8/2025Q1 2025
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
N/A-$0.48N/A-$0.48N/AN/A
3/3/2025Q4 2024
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
-$0.68-$0.57+$0.11-$0.57N/AN/A
2/28/2025Q4 2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.53$0.55+$0.02-$3.84$2.68 billion$2.70 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/A
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
N/AN/AN/AN/AN/A
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$1.043.32%N/A67.53%N/A
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/A
33.42
33.42
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.11
1.09
0.45
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
0.34
1.37
0.76
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
N/A
3.55
3.55

Institutional Ownership

CompanyInstitutional Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
90.37%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
98.04%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
85.43%
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
38.05%

Insider Ownership

CompanyInsider Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
24.17%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
3.69%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
1.90%
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
2.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
BELLUS Health Inc. stock logo
BLU
BELLUS Health
74126.81 million96.16 millionNot Optionable
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
22,50077.26 million74.34 millionOptionable
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
7,70088.47 million86.64 millionOptionable
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
3048.31 million43.78 millionOptionable

Recent News About These Companies

Cassava takes next step for African AI
Cassava Sciences chief medical officer James Kupiec to retire

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BELLUS Health stock logo

BELLUS Health NASDAQ:BLU

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Owens & Minor stock logo

Owens & Minor NYSE:OMI

$7.16 +0.15 (+2.07%)
Closing price 03:59 PM Eastern
Extended Trading
$7.16 0.00 (0.00%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

Patterson Companies stock logo

Patterson Companies NASDAQ:PDCO

$31.33 0.00 (0.00%)
As of 04/17/2025

Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.

Cassava Sciences stock logo

Cassava Sciences NASDAQ:SAVA

$1.83 +0.06 (+3.39%)
Closing price 04:00 PM Eastern
Extended Trading
$1.85 +0.02 (+1.04%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.